BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 7, 2006
View Archived Issues
Novel format of a TRAIL fusion protein presented at a recent meeting
Read More
Therapeutic benefits of p38 MAP kinase inhibition for MDS
Read More
Phase IIa study under way for MEM-1003 in bipolar disorder
Read More
Two phase III studies of alfimeprase complete enrollment
Read More
MAXY-G34 for chemotherapy-induced neutropenia studied in phase I
Read More
Repros updates progress of clinical trials
Read More
Clearance for phase II trial of TroVax in late-stage breast cancer
Read More
eligen technology delivers active recombinant human growth hormone in study
Read More
Pharmos and Vela revise acquisition agreement
Read More
MAP-0004 studied for acute migraine headaches in new phase II trial
Read More
AnorMED Board recommends shareholders reject hostile Genzyme offer
Read More
RIO trials show efficacy of rimonabant in diabetic and nondiabetic overweight/obese patients
Read More
SEPI-PCI trial compares the efficacy and safety of otamixaban with UFH in PCI interventions
Read More
Multiple-dose pharmacokinetics and pharmacodynamics of AZD-6140 reported in healthy subjects
Read More
Logical Therapeutics inlicenses novel NSAID
Read More
Santhera and Juvantia collaborate on fipamezole for Parkinson's dyskinesia
Read More
Zealand raises capital for R&D
Read More
Enrollment completed in several phase III studies of ferumoxytol
Read More
Coprimary endpoints not met in phase III trial of LidoPAIN
Read More
rhThrombin offers good efficacy, better immunogenicity than bovine thrombin
Read More
NDA for CIP-Tramadol ER accepted for review
Read More
Recent patents describe new compounds for diabetes and related disorders
Read More
European orphan drug status for Neuprex in meningococcal disease
Read More
Glumetza now available in U.S.
Read More
Advisory Committee recommends against approval of Genasense in CLL
Read More
Novel nebivolol metabolites for cardiovascular disorders disclosed in recent Mylan patents
Read More
Novel compounds claimed for treatment of inflammatory disorders in recent patents
Read More